Prognostic outcomes of GBM patients were predicted by exploring radiomics signatures constructed using the GlioVis database, and distributions of Radscores and maximally selected rank statistics were used to determine optimal cutoff values for the CCNB1, CDC42, MAPK7, and CD44 oncogenes. Here, CD44 is linked to glioblastoma.